Tag Archive for ‘non-small cell lung cancer’

Figure 1. Overall schema of ALCHEMIST

In search of the philosopher’s stone: The ALCHEMIST study for lung cancer

This month’s column provides an update on the ALCHEMIST trials for patients with operable lung cancer, including the addition of a third arm to study, which permits the inclusion of patients without ALK or EGFR mutations.

Figure 1. ALCHEMIST schema

Biomarker-driven adjuvant targeted therapy for NSCLC—the ALCHEMIST trials

This month’s column summarizes the ALCHEMIST (Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trials) platform and how it facilities definitive studies of adjuvant targeted therapies in biomarker-selected non-small cell lung cancer patients.

Alliance for Clinical Trials in Oncology

Limited resection as a cure for early lung cancer: Time to challenge the gold standard?

A clinical trial is exploring whether limited resection should replace lobectomy as the gold standard for treatment of early-stage lung cancer.

Lung surgery trial algorithm

Alliance leads thoracic surgery trials for lung cancer in 2012

Two lung surgery clinical trials are currently being conducted through the Alliance for Clinical Trials in Oncology. These two trials are highlighted in the accompanying diagram (see Figure) with an algorithm to assist in decision making and patient eligibility. The surgical standard of care for early-stage non-small cell lung cancer (NSCLC) is an anatomic lobectomy […]

Contact

Bulletin of the American College of Surgeons
633 N. Saint Clair St.
Chicago, IL 60611

Archives

Download the Bulletin App


Get it on Google Play